Aurobindo Pharma Lands In Patent Litigation Cases In USA

HYDERABAD: Three multinational drug makers - The Medicines Company, Hospira and Kowa Company Ltd - in separate cases - have dragged Indian firm Aurobindo Pharma to court on allegations of patent infringement.

According to the petition copies, Hospira has alleged that Aurobindo's Abbreviated New Drug Application (ANDA) to make generic version of dexmedetomidine hydrochloride injection would infringe its patented drug Precedex.

Aurobindo officials were unavailable for comments.

However, a market analyst said that "these patent infringement cases are not uncommon for generic drug maker.

The product launch will depend on the outcome of the court and US FDA approvals".

Hospira filed the petition in the US District Court of Delaware. The drug is used for the sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting.

Similarly, the Medicines Company in a separate petition filed in the District Court of New Jersey alleged that the Indian drug maker's ANDA would infringe on it's drug - Angiomax- on two counts.
READ MORE:
India Seeks Crucial Reforms of UN Security Institutions
U.S. Court Dismisses 1984 Riots Case Against Congress